Physician profile
Stephen J Odom
NPI 1740253749
$599,385.69
in general payments reported to CMS, 2019-2025
19 companies · $93K in 2025
The $93K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110K · 2020: $68K · 2021: $90K · 2022: $93K · 2023: $77K · 2024: $67K · 2025: $93K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $194K · Consulting Fee: $19K · Travel and Lodging: $13K · Food and Beverage: $7,079 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,750 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $193,900.00 |
| Consulting Fee | $18,950.00 |
| Travel and Lodging | $12,501.92 |
| Food and Beverage | $7,078.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,750.00 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $551,187.70 | 2019-2025 | Da Vinci Surgical System |
| Globus Medical, INC. | $43,596.18 | 2019-2025 | Alif, Corbel, Excelsius Gps |
| Camber Spine Technologies LLC | $2,472.04 | 2021-2022 | |
| Davol INC. | $595.76 | 2019-2023 | Phasix Mesh |
| Tela Bio, INC. | $350.09 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Aroa Biosurgery Incorporated | $235.23 | 2022-2024 | |
| Enterra Medical, INC. | $175.86 | 2025 | |
| Conmed Corporation | $159.27 | 2024-2025 | Airseal |
| Heron Therapeutics, INC. | $158.66 | 2021-2023 | Zynrelef |
| Medtronic USA, INC. | $115.61 | 2020 | |
| Kerecis Limited | $83.33 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Covidien LP | $55.56 | 2020 | |
| Baxter Healthcare | $51.12 | 2021-2022 | |
| Edwards Lifesciences Corporation | $37.45 | 2022 | |
| Ethicon US, LLC | $35.73 | 2019-2024 | Harmonic |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $23.94 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $18.99 | 2019 | |
| Smith+Nephew, INC. | $17.62 | 2019 | |
| Merck Sharp & Dohme LLC | $15.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Odom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.